Predicting infection risk in rheumatoid arthritis patients receiving biological or targeted synthetic disease-modifying anti-rheumatic drugs: an application of machine learning and healthcare big data

BMC Medical Informatics and Decision Making · Published 2026-08-05 · DOI 10.1186/s12911-026-03739-z

Free full text

Authors (14)

Kuan Peng, Deliang Yang, Jiaqi Wang, Chin-Yao Shen, Michael Chun-Yuan Cheng, Shirley C. W. Chan, Iris Y. K. Tang, Qingpeng Zhang, Edward Chia‑Cheng Lai, Nicole L. Pratt, Ian Chi Kei Wong, Chak-sing Lau, Jeff Jianfei Guo, Xue Li

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Peng, K., Yang, D., Wang, J., et al. (2026). Predicting infection risk in rheumatoid arthritis patients receiving biological or targeted synthetic disease-modifying anti-rheumatic drugs: an application of machine learning and healthcare big data. BMC Medical Informatics and Decision Making. https://doi.org/10.1186/s12911-026-03739-z

Related articles